A detailed history of Camelot Portfolios, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Camelot Portfolios, LLC holds 79 shares of GILD stock, worth $7,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Holding current value
$7,734
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $4,988 - $5,757
79 New
79 $5,000
Q4 2022

Jan 25, 2023

SELL
$62.32 - $89.47 $140,905 - $202,291
-2,261 Reduced 40.25%
3,356 $0
Q3 2022

Oct 31, 2022

SELL
$59.54 - $68.01 $95,085 - $108,611
-1,597 Reduced 22.14%
5,617 $347,000
Q2 2022

Jul 18, 2022

BUY
$57.72 - $65.01 $106,724 - $120,203
1,849 Added 34.46%
7,214 $446,000
Q1 2022

Apr 20, 2022

SELL
$57.92 - $72.58 $194,379 - $243,578
-3,356 Reduced 38.48%
5,365 $319,000
Q4 2021

Jan 04, 2022

BUY
$64.88 - $73.64 $55,602 - $63,109
857 Added 10.9%
8,721 $633,000
Q3 2021

Nov 04, 2021

SELL
$67.69 - $73.03 $81,972 - $88,439
-1,211 Reduced 13.34%
7,864 $549,000
Q2 2021

Jul 28, 2021

BUY
$63.47 - $69.35 $575,990 - $629,351
9,075 New
9,075 $625,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $123B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Camelot Portfolios, LLC Portfolio

Follow Camelot Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.